drugset / Trial / NCT01448525

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

NCT01448525

Phase 4 Completed 88 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.

Timeline

Start
2011-10
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bimatoprost Other / unclassified 0.03 % Topical

Indications